We provide you with 20 years of free, institutional-grade data for MLAB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MLAB. Explore the full financial landscape of MLAB stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$770,126
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Archbold Brian David | Sale | -2,516 | $89.5 | $225,187 | 2026-06-23 |
| Archbold Brian David | Grant, award...etc | 1,859 | $95.1 | 2026-06-23 | |
| Archbold Brian David | Derivatives Exercise | 3,324 | 2026-06-23 | ||
| Sakys John | Sale | -2,827 | $89.5 | $253,022 | 2026-06-23 |
| Sakys John | Grant, award...etc | 2,282 | $95.1 | 2026-06-23 | |
| Sakys John | Derivatives Exercise | 3,792 | 2026-06-23 | ||
| Crennen Lyndsey Elizabeth | Sale | -442 | $89.5 | $39,560 | 2026-06-23 |
| Crennen Lyndsey Elizabeth | Grant, award...etc | 263 | $95.1 | 2026-06-23 | |
| Crennen Lyndsey Elizabeth | Derivatives Exercise | 726 | 2026-06-23 | ||
| Crennen Lyndsey Elizabeth | Sale | -118 | $101.27 | $11,950 | 2026-06-17 |
| Sakys John | Sale | -1,223 | $101.27 | $123,850 | 2026-06-17 |
| Archbold Brian David | Sale | -1,151 | $101.27 | $116,558 | 2026-06-17 |
| Archbold Brian David | Derivatives Exercise | 2,454 | 2026-06-16 | ||
| Sakys John | Derivatives Exercise | 2,717 | 2026-06-16 | ||
| Crennen Lyndsey Elizabeth | Initial | 2026-06-16 | |||
| Ladiwala Shiraz Shabanali | Open Market Purchase | 3,500 | $72.23 | 2026-03-10 | |
| Capone Mark Christopher | Open Market Purchase | 1,301 | $76.35 | 2026-03-10 | |
| Tripeny R Tony | Open Market Purchase | 1,315 | $76 | 2026-03-10 | |
| Owens Gary M | Derivatives Exercise | 11,558 | 2025-10-28 | ||
| Capone Mark Christopher | Derivatives Exercise | 1,404 | 2025-08-18 | ||
| Tripeny R Tony | Derivatives Exercise | 1,404 | 2025-08-18 | ||
| Alltoft Jennifer Sadie | Derivatives Exercise | 1,404 | 2025-08-18 | ||
| Ladiwala Shiraz Shabanali | Derivatives Exercise | 1,949 | 2025-08-18 | ||
| Hall Shannon | Derivatives Exercise | 1,404 | 2025-08-18 | ||
| Sullivan John James | Derivatives Exercise | 1,404 | 2025-08-18 | ||
| Sakys John | Sale | -454 | $95.82 | $43,502 | 2025-06-25 |
| Sakys John | Derivatives Exercise | 1,036 | 2025-06-25 | ||
| Archbold Brian David | Sale | -385 | $95.82 | $36,891 | 2025-06-25 |
| Archbold Brian David | Derivatives Exercise | 844 | 2025-06-25 | ||
| Owens Gary M | Sale | -1,445 | $95.82 | $138,460 | 2025-06-24 |
| Owens Gary M | Derivatives Exercise | 3,301 | 2025-06-24 | ||
| Archbold Brian David | Sale | -1,166 | $92.99 | $108,426 | 2025-06-20 |
| Archbold Brian David | Derivatives Exercise | 2,556 | 2025-06-20 | ||
| Sakys John | Sale | -1,243 | $92.99 | $115,587 | 2025-06-20 |
| Sakys John | Derivatives Exercise | 2,840 | 2025-06-20 | ||
| Owens Gary M | Sale | -3,810 | $92.99 | $354,292 | 2025-06-20 |
| Owens Gary M | Derivatives Exercise | 8,707 | 2025-06-20 | ||
| Owens Gary M | Sale | -1,939 | $97.12 | $188,312 | 2025-06-18 |
| Owens Gary M | Derivatives Exercise | 4,426 | 2025-06-18 | ||
| Archbold Brian David | Sale | -472 | $97.12 | $45,840 | 2025-06-18 |
| Archbold Brian David | Derivatives Exercise | 1,030 | 2025-06-18 | ||
| Sakys John | Sale | -642 | $97.12 | $62,350 | 2025-06-18 |
| Sakys John | Grant, award...etc | 668 | 2025-06-18 | ||
| Sakys John | Derivatives Exercise | 793 | 2025-06-18 | ||
| Owens Gary M | Sale | -21,000 | $123.91 | $2,602,110 | 2025-03-24 |
| Owens Gary M | Derivatives Exercise | 21,000 | 2025-03-24 | ||
| Owens Gary M | Sale | -5,069 | $113.62 | $575,920 | 2024-10-29 |
| Owens Gary M | Grant, award...etc | 11,559 | 2024-10-29 | ||
| Archbold Brian David | Sale | -1,499 | $125 | $187,375 | 2024-09-16 |
| Hall Shannon | Derivatives Exercise | 1,074 | 2024-09-06 | ||
| Ladiwala Shiraz Shabanali | Derivatives Exercise | 1,574 | 2024-09-06 | ||
| Tripeny R Tony | Derivatives Exercise | 1,074 | 2024-09-06 | ||
| Alltoft Jennifer Sadie | Derivatives Exercise | 1,074 | 2024-09-06 | ||
| Owens Gary M | Sale | -1,445 | $133.69 | $193,182 | 2024-09-06 |
| Owens Gary M | Derivatives Exercise | 3,301 | 2024-09-06 | ||
| Sakys John | Sale | -454 | $133.69 | $60,695 | 2024-09-06 |
| Sakys John | Derivatives Exercise | 1,037 | 2024-09-06 | ||
| Sullivan John James | Derivatives Exercise | 1,074 | 2024-09-06 | ||
| Archbold Brian David | Sale | -386 | $133.69 | $51,604 | 2024-09-06 |
| Archbold Brian David | Derivatives Exercise | 845 | 2024-09-06 | ||
| Capone Mark Christopher | Derivatives Exercise | 724 | 2024-08-19 | ||
| Sakys John | Sale | -572 | $91.6 | $52,395 | 2024-06-17 |
| Sakys John | Derivatives Exercise | 1,304 | 2024-06-17 | ||
| Archbold Brian David | Sale | -407 | $91.6 | $37,281 | 2024-06-17 |
| Archbold Brian David | Derivatives Exercise | 889 | 2024-06-17 | ||
| Owens Gary M | Derivatives Exercise | 4,959 | 2024-06-17 | ||
| Archbold Brian David | Sale | -1,500 | $112.36 | $168,540 | 2023-12-19 |
| Schmieder John Bradley | Sale | -4,000 | $123.05 | $492,200 | 2023-09-19 |
| Schmieder John Bradley | Sale | -3,000 | $123.32 | $369,965 | 2023-09-14 |
| Ladiwala Shiraz Shabanali | Derivatives Exercise | 40 | 2023-09-06 | ||
| Owens Gary M | Sale | -2,000 | $142.82 | $285,640 | 2023-09-05 |
| Owens Gary M | Derivatives Exercise | 2,000 | 2023-09-05 | ||
| Ladiwala Shiraz Shabanali | Derivatives Exercise | 1,055 | 2023-08-16 | ||
| Sullivan John James | Derivatives Exercise | 754 | 2023-08-16 | ||
| Schmieder John Bradley | Derivatives Exercise | 754 | 2023-08-16 | ||
| Alltoft Jennifer Sadie | Derivatives Exercise | 754 | 2023-08-16 | ||
| Hall Shannon | Derivatives Exercise | 754 | 2023-08-16 | ||
| Tripeny R Tony | Derivatives Exercise | 1,105 | 2023-08-16 | ||
| Sakys John | Sale | -288 | $135.55 | $39,038 | 2023-06-21 |
| Sakys John | Derivatives Exercise | 848 | 2023-06-21 | ||
| Sullivan John James | Sale | -6 | $135.55 | $813 | 2023-06-21 |
| Sullivan John James | Derivatives Exercise | 15 | 2023-06-21 | ||
| Archbold Brian David | Sale | -189 | $135.55 | $25,619 | 2023-06-21 |
| Archbold Brian David | Derivatives Exercise | 612 | 2023-06-21 | ||
| Owens Gary M | Sale | -945 | $135.55 | $128,095 | 2023-06-21 |
| Owens Gary M | Derivatives Exercise | 2,820 | 2023-06-21 | ||
| Archbold Brian David | Sale | -283 | $134.45 | $38,049 | 2023-06-16 |
| Archbold Brian David | Derivatives Exercise | 614 | 2023-06-16 | ||
| Sakys John | Sale | -373 | $134.45 | $50,150 | 2023-06-16 |
| Sakys John | Derivatives Exercise | 848 | 2023-06-16 | ||
| Schmieder John Bradley | Derivatives Exercise | 30 | 2023-06-16 | ||
| Sullivan John James | Sale | -6 | $134.45 | $807 | 2023-06-16 |
| Sullivan John James | Derivatives Exercise | 15 | 2023-06-16 | ||
| Owens Gary M | Sale | -1,237 | $134.45 | $166,315 | 2023-06-16 |
| Owens Gary M | Derivatives Exercise | 2,823 | 2023-06-16 | ||
| Sakys John | Sale | -4,628 | $171.62 | $794,257 | 2023-03-27 |
| Sakys John | Derivatives Exercise | 4,628 | 2023-03-27 | ||
| Sakys John | Sale | -1,000 | $165.71 | $165,710 | 2023-03-16 |
| Sakys John | Derivatives Exercise | 1,000 | 2023-03-16 | ||
| Sakys John | Sale | -400 | $169.97 | $67,988 | 2023-03-09 |
| Sakys John | Derivatives Exercise | 400 | 2023-03-09 | ||
| Sakys John | Sale | -1,000 | $184.27 | $184,270 | 2023-02-09 |
| Sakys John | Derivatives Exercise | 1,000 | 2023-02-09 | ||
| Sakys John | Sale | -2,100 | $210.19 | $441,399 | 2023-01-25 |
| Sakys John | Derivatives Exercise | 2,100 | 2023-01-25 | ||
| Schmieder John Bradley | Sale | -3,142 | $191.31 | $601,096 | 2023-01-17 |
| Hall Shannon | Sale | -230 | $174.97 | $40,244 | 2022-12-09 |
The information provided in this report about MLAB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Mesa Laboratories, Inc(NASDAQ:MLAB) 
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-co...
Website: http://www.mesalabs.com
Founded: 1982
Full Time Employees: 460
Sector: Technology
Industry: Scientific & Technical Instruments